Report cover image

Global Anti-allergic Drugs Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20360984

Description

Summary

According to APO Research, The global Anti-allergic Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Anti-allergic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Anti-allergic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Anti-allergic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Anti-allergic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Anti-allergic Drugs include GlaxoSmithKline, Johnson And Johnson, Sun Pharma, UCB Pharma, AstraZeneca, Bayer, Dawnrays, Chongqing Huapont Pharmaceutical and Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Anti-allergic Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Anti-allergic Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-allergic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-allergic Drugs revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Anti-allergic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Anti-allergic Drugs revenue, projected growth trends, production technology, application and end-user industry.

Anti-allergic Drugs Segment by Company

GlaxoSmithKline
Johnson And Johnson
Sun Pharma
UCB Pharma
AstraZeneca
Bayer
Dawnrays
Chongqing Huapont Pharmaceutical
Roche
Merck
Novartis
Hainan Poly Pharm
Sanofi
Teva
Yangtze River Pharmaceutical Group
Anti-allergic Drugs Segment by Type

Inhalation and Nasal Sprays
Non-Oral Drugs
Oral Drugs
Anti-allergic Drugs Segment by Application

Online
Offline
Anti-allergic Drugs Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-allergic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Anti-allergic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Anti-allergic Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-allergic Drugs revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Anti-allergic Drugs Market by Type
1.2.1 Global Anti-allergic Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Inhalation and Nasal Sprays
1.2.3 Non-Oral Drugs
1.2.4 Oral Drugs
1.3 Anti-allergic Drugs Market by Application
1.3.1 Global Anti-allergic Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online
1.3.3 Offline
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Anti-allergic Drugs Market Dynamics
2.1 Anti-allergic Drugs Industry Trends
2.2 Anti-allergic Drugs Industry Drivers
2.3 Anti-allergic Drugs Industry Opportunities and Challenges
2.4 Anti-allergic Drugs Industry Restraints
3 Global Growth Perspective
3.1 Global Anti-allergic Drugs Market Perspective (2020-2031)
3.2 Global Anti-allergic Drugs Growth Trends by Region
3.2.1 Global Anti-allergic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Anti-allergic Drugs Market Size by Region (2020-2025)
3.2.3 Global Anti-allergic Drugs Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Anti-allergic Drugs Revenue by Players
4.1.1 Global Anti-allergic Drugs Revenue by Players (2020-2025)
4.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2020-2025)
4.1.3 Global Anti-allergic Drugs Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Anti-allergic Drugs Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Anti-allergic Drugs Key Players Headquarters & Area Served
4.4 Global Anti-allergic Drugs Players, Product Type & Application
4.5 Global Anti-allergic Drugs Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Anti-allergic Drugs Market CR5 and HHI
4.6.3 2024 Anti-allergic Drugs Tier 1, Tier 2, and Tier 3
5 Anti-allergic Drugs Market Size by Type
5.1 Global Anti-allergic Drugs Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Anti-allergic Drugs Revenue by Type (2020-2031)
5.3 Global Anti-allergic Drugs Revenue Market Share by Type (2020-2031)
6 Anti-allergic Drugs Market Size by Application
6.1 Global Anti-allergic Drugs Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Anti-allergic Drugs Revenue by Application (2020-2031)
6.3 Global Anti-allergic Drugs Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Comapny Information
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.1.4 GlaxoSmithKline Anti-allergic Drugs Product Portfolio
7.1.5 GlaxoSmithKline Recent Developments
7.2 Johnson And Johnson
7.2.1 Johnson And Johnson Comapny Information
7.2.2 Johnson And Johnson Business Overview
7.2.3 Johnson And Johnson Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.2.4 Johnson And Johnson Anti-allergic Drugs Product Portfolio
7.2.5 Johnson And Johnson Recent Developments
7.3 Sun Pharma
7.3.1 Sun Pharma Comapny Information
7.3.2 Sun Pharma Business Overview
7.3.3 Sun Pharma Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.3.4 Sun Pharma Anti-allergic Drugs Product Portfolio
7.3.5 Sun Pharma Recent Developments
7.4 UCB Pharma
7.4.1 UCB Pharma Comapny Information
7.4.2 UCB Pharma Business Overview
7.4.3 UCB Pharma Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.4.4 UCB Pharma Anti-allergic Drugs Product Portfolio
7.4.5 UCB Pharma Recent Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Comapny Information
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.5.4 AstraZeneca Anti-allergic Drugs Product Portfolio
7.5.5 AstraZeneca Recent Developments
7.6 Bayer
7.6.1 Bayer Comapny Information
7.6.2 Bayer Business Overview
7.6.3 Bayer Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.6.4 Bayer Anti-allergic Drugs Product Portfolio
7.6.5 Bayer Recent Developments
7.7 Dawnrays
7.7.1 Dawnrays Comapny Information
7.7.2 Dawnrays Business Overview
7.7.3 Dawnrays Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.7.4 Dawnrays Anti-allergic Drugs Product Portfolio
7.7.5 Dawnrays Recent Developments
7.8 Chongqing Huapont Pharmaceutical
7.8.1 Chongqing Huapont Pharmaceutical Comapny Information
7.8.2 Chongqing Huapont Pharmaceutical Business Overview
7.8.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.8.4 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product Portfolio
7.8.5 Chongqing Huapont Pharmaceutical Recent Developments
7.9 Roche
7.9.1 Roche Comapny Information
7.9.2 Roche Business Overview
7.9.3 Roche Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.9.4 Roche Anti-allergic Drugs Product Portfolio
7.9.5 Roche Recent Developments
7.10 Merck
7.10.1 Merck Comapny Information
7.10.2 Merck Business Overview
7.10.3 Merck Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.10.4 Merck Anti-allergic Drugs Product Portfolio
7.10.5 Merck Recent Developments
7.11 Novartis
7.11.1 Novartis Comapny Information
7.11.2 Novartis Business Overview
7.11.3 Novartis Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.11.4 Novartis Anti-allergic Drugs Product Portfolio
7.11.5 Novartis Recent Developments
7.12 Hainan Poly Pharm
7.12.1 Hainan Poly Pharm Comapny Information
7.12.2 Hainan Poly Pharm Business Overview
7.12.3 Hainan Poly Pharm Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.12.4 Hainan Poly Pharm Anti-allergic Drugs Product Portfolio
7.12.5 Hainan Poly Pharm Recent Developments
7.13 Sanofi
7.13.1 Sanofi Comapny Information
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.13.4 Sanofi Anti-allergic Drugs Product Portfolio
7.13.5 Sanofi Recent Developments
7.14 Teva
7.14.1 Teva Comapny Information
7.14.2 Teva Business Overview
7.14.3 Teva Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.14.4 Teva Anti-allergic Drugs Product Portfolio
7.14.5 Teva Recent Developments
7.15 Yangtze River Pharmaceutical Group
7.15.1 Yangtze River Pharmaceutical Group Comapny Information
7.15.2 Yangtze River Pharmaceutical Group Business Overview
7.15.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Revenue and Gross Margin (2020-2025)
7.15.4 Yangtze River Pharmaceutical Group Anti-allergic Drugs Product Portfolio
7.15.5 Yangtze River Pharmaceutical Group Recent Developments
8 North America
8.1 North America Anti-allergic Drugs Revenue (2020-2031)
8.2 North America Anti-allergic Drugs Revenue by Type (2020-2031)
8.2.1 North America Anti-allergic Drugs Revenue by Type (2020-2025)
8.2.2 North America Anti-allergic Drugs Revenue by Type (2026-2031)
8.3 North America Anti-allergic Drugs Revenue Share by Type (2020-2031)
8.4 North America Anti-allergic Drugs Revenue by Application (2020-2031)
8.4.1 North America Anti-allergic Drugs Revenue by Application (2020-2025)
8.4.2 North America Anti-allergic Drugs Revenue by Application (2026-2031)
8.5 North America Anti-allergic Drugs Revenue Share by Application (2020-2031)
8.6 North America Anti-allergic Drugs Revenue by Country
8.6.1 North America Anti-allergic Drugs Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Anti-allergic Drugs Revenue by Country (2020-2025)
8.6.3 North America Anti-allergic Drugs Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Anti-allergic Drugs Revenue (2020-2031)
9.2 Europe Anti-allergic Drugs Revenue by Type (2020-2031)
9.2.1 Europe Anti-allergic Drugs Revenue by Type (2020-2025)
9.2.2 Europe Anti-allergic Drugs Revenue by Type (2026-2031)
9.3 Europe Anti-allergic Drugs Revenue Share by Type (2020-2031)
9.4 Europe Anti-allergic Drugs Revenue by Application (2020-2031)
9.4.1 Europe Anti-allergic Drugs Revenue by Application (2020-2025)
9.4.2 Europe Anti-allergic Drugs Revenue by Application (2026-2031)
9.5 Europe Anti-allergic Drugs Revenue Share by Application (2020-2031)
9.6 Europe Anti-allergic Drugs Revenue by Country
9.6.1 Europe Anti-allergic Drugs Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Anti-allergic Drugs Revenue by Country (2020-2025)
9.6.3 Europe Anti-allergic Drugs Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Anti-allergic Drugs Revenue (2020-2031)
10.2 China Anti-allergic Drugs Revenue by Type (2020-2031)
10.2.1 China Anti-allergic Drugs Revenue by Type (2020-2025)
10.2.2 China Anti-allergic Drugs Revenue by Type (2026-2031)
10.3 China Anti-allergic Drugs Revenue Share by Type (2020-2031)
10.4 China Anti-allergic Drugs Revenue by Application (2020-2031)
10.4.1 China Anti-allergic Drugs Revenue by Application (2020-2025)
10.4.2 China Anti-allergic Drugs Revenue by Application (2026-2031)
10.5 China Anti-allergic Drugs Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Anti-allergic Drugs Revenue (2020-2031)
11.2 Asia Anti-allergic Drugs Revenue by Type (2020-2031)
11.2.1 Asia Anti-allergic Drugs Revenue by Type (2020-2025)
11.2.2 Asia Anti-allergic Drugs Revenue by Type (2026-2031)
11.3 Asia Anti-allergic Drugs Revenue Share by Type (2020-2031)
11.4 Asia Anti-allergic Drugs Revenue by Application (2020-2031)
11.4.1 Asia Anti-allergic Drugs Revenue by Application (2020-2025)
11.4.2 Asia Anti-allergic Drugs Revenue by Application (2026-2031)
11.5 Asia Anti-allergic Drugs Revenue Share by Application (2020-2031)
11.6 Asia Anti-allergic Drugs Revenue by Country
11.6.1 Asia Anti-allergic Drugs Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Anti-allergic Drugs Revenue by Country (2020-2025)
11.6.3 Asia Anti-allergic Drugs Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Anti-allergic Drugs Revenue (2020-2031)
12.2 SAMEA Anti-allergic Drugs Revenue by Type (2020-2031)
12.2.1 SAMEA Anti-allergic Drugs Revenue by Type (2020-2025)
12.2.2 SAMEA Anti-allergic Drugs Revenue by Type (2026-2031)
12.3 SAMEA Anti-allergic Drugs Revenue Share by Type (2020-2031)
12.4 SAMEA Anti-allergic Drugs Revenue by Application (2020-2031)
12.4.1 SAMEA Anti-allergic Drugs Revenue by Application (2020-2025)
12.4.2 SAMEA Anti-allergic Drugs Revenue by Application (2026-2031)
12.5 SAMEA Anti-allergic Drugs Revenue Share by Application (2020-2031)
12.6 SAMEA Anti-allergic Drugs Revenue by Country
12.6.1 SAMEA Anti-allergic Drugs Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Anti-allergic Drugs Revenue by Country (2020-2025)
12.6.3 SAMEA Anti-allergic Drugs Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.